Home Newsfeeds Wolfe Research Downgrades TripAdvisor to Underperform, Announces $17 Price Target

Wolfe Research Downgrades TripAdvisor to Underperform, Announces $17 Price Target

Wolfe Research analyst Deepak Mathivanan downgrades TripAdvisor (NASDAQ:TRIP) from Peer Perform to Underperform and announces $17 price target.

byBenzinga Newsdesk

December 7, 2022

1 minute read

Wolfe Research analyst Deepak Mathivanan downgrades TripAdvisor (NASDAQ:TRIP) from Peer Perform to Underperform and announces $17 price target.

News

Altus Power, Inc. Announces Redemption Of Public And Private Placement Warrants

By Benzinga Newsdesk

September 15, 6:46 AM

Altus Power, Inc. (NYSE:AMPS) ("Altus Power" or the "Company"), the premier independent developer, owner and operator of commercial-scale solar facilities, today announced that it will redeem all of

AMPS

Qualigen Therapeutics Announces First Patient Dosed In The Phase 1a Clinical Trial Of QN-302 For Treatment Of Advanced Or Metastatic Solid Tumors

By Benzinga Newsdesk

November 7, 9:33 AM

Qualigen Therapeutics, Inc. (NASDAQ:QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announces today that the first

QLGN

Why Lucid Stock Is Hitting The Brakes Thursday

By Adam Eckert

June 1, 8:36 AM

Lucid Group Inc (NASDAQ: LCID) shares are moving lower Thursday after the company announced the pricing of a publ

LCID

Trump Expects To Be Arrested Next Week, Elon Musk Shares Thoughts Ahead Of Former President’s Possible Indictment

By Bibhu Pattnaik

March 18, 2:12 PM

On Saturday, former president Donald Trump announced on his Truth Social platform that he expects to be arrested this coming Tuesday in light of an investigation over a

Wolfe Research Downgrades TripAdvisor to Underperform, Announces $17 Price Target

Related Posts

Altus Power, Inc. Announces Redemption Of Public And Private Placement Warrants

Qualigen Therapeutics Announces First Patient Dosed In The Phase 1a Clinical Trial Of QN-302 For Treatment Of Advanced Or Metastatic Solid Tumors

Why Lucid Stock Is Hitting The Brakes Thursday

Trump Expects To Be Arrested Next Week, Elon Musk Shares Thoughts Ahead Of Former President’s Possible Indictment